SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-007745
Filing Date
2021-07-08
Accepted
2021-07-08 08:31:13
Documents
11
Period of Report
2021-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tenx_8k.htm 8-K 59479
2 FORM OF UNREGISTERED PRE-FUNDED WARRANT tenx_ex41.htm EX-4.1 107934
3 FORM OF UNREGISTERED WARRANT tenx_ex42.htm EX-4.2 113120
4 FORM OF HCW WARRANT (2021) tenx_ex43.htm EX-4.3 126922
5 SECURITIES PURCHASE AGREEMENT tenx_ex101.htm EX-10.1 258636
6 REGISTRATION RIGHTS AGREEMENT tenx_ex102.htm EX-10.2 169718
7 SEPARATION AND GENERAL RELEASE AGREEMENT tenx_ex103.htm EX-10.3 57951
8 EXECUTIVE EMPLOYMENT AGREEMENT tenx_ex104.htm EX-10.4 102497
9 PLAN FOR EMPLOYEE INDUCEMENT STOCK OPTIONS tenx_ex105.htm EX-10.5 181523
10 PRESS RELEASE tenx_ex991.htm EX-99.1 22048
11 IMAGE tenx_ex991000.jpg GRAPHIC 4441
  Complete submission text file 0001654954-21-007745.txt   1207807
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 211079015
SIC: 2834 Pharmaceutical Preparations